ESC 365 - Novel anti-obesity drugs in weight management.

Open Access

Novel anti-obesity drugs in weight management.

Session: Obesity and CV disease – Lowering CV risk with novel weight loss strategies

Topic: Obesity and Diabetes

Speaker: Professor H. Colhoun (Edinburgh, GB)

Sponsored by Medscape Education Global

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Helen Colhoun

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

5 more presentations in this session

Why do cardiologists need to manage obesity?

Speaker: Professor J. Deanfield (London, GB)

From pathophysiology to obesity management.

Speaker: Professor L. Van Gaal (Edegem-Antwerp, BE)

Cases of multi-disciplinary obesity care in clinical practice.

Speaker: Professor L. Van Gaal (Edegem-Antwerp, BE)

Weight loss trials on CVD benefit.

Take home messages for cardiovascular practitioners.

Speaker: Professor J. Deanfield (London, GB)

Access the full session

Obesity and CV disease – Lowering CV risk with novel weight loss strategies

Speakers: Professor H. Colhoun, Professor J. Deanfield, Professor L. Van Gaal, Professor L. Van Gaal, Professor J. Deanfield

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources